Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction?
Engroff
Stephen L
SL
Head and Neck Surgery of Central Pennsylvania, Division of Tri-County Oral-Facial Surgeons, State College, PA 16801, USA. stephen_engroff@msn.com
Kim
Dongsoo David
DD
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001860:Bone Plates; D016025:Bone Transplantation / Q000379:methods; D001943:Breast Neoplasms / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects; D008336:Mandibular Diseases / Q000139:chemically induced* / Q000601:surgery; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced* / Q000601:surgery; D000077268:Pamidronate; D019651:Plastic Surgery Procedures / Q000379:methods*; D013524:Surgical Flaps; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D000077268:Pamidronate